Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
04.02.24
-
04.02.25
-
23.09.22

StockNews.com 
04.02.24 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.071
04.02.24
-
04.02.25
-9.93%
05.03.24

StockNews.com 
04.02.24 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.22
04.02.24
-
04.02.25
-
15.12.23

StockNews.com 
04.02.24 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
04.02.24
-
04.02.25
-
23.12.22

StockNews.com 
04.02.24 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€5.60
04.02.24
-
04.02.25
-14.64%
30.08.24

StockNews.com 
04.02.24 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.14
04.02.24
-
04.02.25
-
08.09.23

StockNews.com 
04.02.24 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.61
04.02.24
-
04.02.25
-32.46%
22.02.24

StockNews.com 
04.02.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.00
04.02.24
€7.00
31.03.26
22.50%
30.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 70%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€14.10
04.02.24
€22.00
31.03.26
-14.18%
30.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.00
03.02.24
-
03.02.25
-6.65%
02.09.24

StockNews.com 
03.02.24 50%
sell
Omeros Corp.

Start price
Target price
Perf. (%)
€3.03
03.02.24
-
03.02.25
23.75%
30.08.24

StockNews.com 
03.02.24 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
03.02.24
-
03.02.25
-
19.09.23

StockNews.com 
03.02.24 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€45.63
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.20
02.02.24
€128.74
02.02.25
-6.81%
02.09.24

Truist Financial Co. 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.60
02.02.24
€137.06
02.02.25
-7.12%
02.09.24

UBS Group AG 
02.02.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€23.60
02.02.24
€38.87
02.02.25
-40.15%
28.08.24

Cantor Fitzgerald 
02.02.24 50%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.48
02.02.24
-
02.02.25
60.03%
02.09.24

StockNews.com 
02.02.24 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.56
02.02.24
-
02.02.25
-68.80%
12.08.24

StockNews.com 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€116.60
02.02.24
€134.11
02.02.25
-6.33%
02.09.24

Barclays PLC 
02.02.24 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€296.60
01.02.24
€322.00
01.02.25
4.11%
02.09.24

Oppenheimer Holdings Inc. 
01.02.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€603.00
01.02.24
€579.60
01.02.25
44.36%
02.09.24

Cantor Fitzgerald 
01.02.24 50%
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€106.50
01.02.24
€128.80
01.02.25
17.44%
02.09.24

Cantor Fitzgerald 
01.02.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.30
01.02.24
€404.41
01.02.25
11.95%
02.09.24

JPMorgan Chase & Co. 
01.02.24 50%